Management to Provide Update on Strategic Acquisit
Post# of 36537
(Total Views: 157)
Posted On: 02/15/2019 10:11:24 AM
Management to Provide Update on Strategic Acquisitions, Financing, Growth Initiatives & Spin Out of NuGenerex Immuno-Oncology
- Potential Acquisition of 13 Hospitals as well as Hospital IT and Management company
- Potential Acquisition of World Class Nutraceutical Company
- Potential Acquisition of Home Delivered Medically Approved Foods Business for Chronic Care of diabetes, cancer, cardiovascular, and rheumatoid arthritis patients
- Acquisition of Direct to Patient End to End Pharmacy Business
- Update on Fuse Medical Acquisition
- Update on Medisource Partners Acquisition
- Update on Pantheon Acquisition
- Update on NuGenerex Immuno-Oncology (NGIO) dividend and Go Public Strategy
- Acquisition plans for NGIO Merger with Company with Synergistic Platforms
- NGIO Acquisition of World Class IP
- Discussion of financial and legal issues
- Potential Acquisition of 13 Hospitals as well as Hospital IT and Management company
- Potential Acquisition of World Class Nutraceutical Company
- Potential Acquisition of Home Delivered Medically Approved Foods Business for Chronic Care of diabetes, cancer, cardiovascular, and rheumatoid arthritis patients
- Acquisition of Direct to Patient End to End Pharmacy Business
- Update on Fuse Medical Acquisition
- Update on Medisource Partners Acquisition
- Update on Pantheon Acquisition
- Update on NuGenerex Immuno-Oncology (NGIO) dividend and Go Public Strategy
- Acquisition plans for NGIO Merger with Company with Synergistic Platforms
- NGIO Acquisition of World Class IP
- Discussion of financial and legal issues
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼